Psychopharmacology of neurobehavioral disorders

Handb Clin Neurol. 2019:165:383-390. doi: 10.1016/B978-0-444-64012-3.00023-X.

Abstract

At times psychotropic drug use is required to address behavioral and other interfering symptoms that accompany neurobehavioral disorders. We review such prescribing practice in autism spectrum disorder, fragile X syndrome, and Prader-Willi syndrome.

Keywords: Autism; Fragile X syndrome; Prader–Willi syndrome; Psychopharmacology.

Publication types

  • Review

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Antipsychotic Agents / therapeutic use
  • Autism Spectrum Disorder / diagnosis
  • Autism Spectrum Disorder / drug therapy*
  • Autism Spectrum Disorder / psychology*
  • Fragile X Syndrome / diagnosis
  • Fragile X Syndrome / drug therapy*
  • Fragile X Syndrome / psychology*
  • Humans
  • Intellectual Disability / diagnosis
  • Intellectual Disability / drug therapy
  • Intellectual Disability / psychology
  • Mental Disorders / diagnosis
  • Mental Disorders / drug therapy
  • Mental Disorders / psychology
  • Prader-Willi Syndrome / diagnosis
  • Prader-Willi Syndrome / drug therapy*
  • Prader-Willi Syndrome / psychology*
  • Psychopharmacology

Substances

  • Antidepressive Agents
  • Antipsychotic Agents